cotidiana.eu

What It Is

COTIDIANA is a patient monitoring solution designed for clinical care, clinical research, and drug trials. It consists of a mobile app for patients and a web app for clinicians and clinical researchers, with the goal of monitoring patient status more comprehensively and efficiently. The available content indicates that the solution is still under development and is expected to be commercialized as a medical device in 2024.

Core Features and Product Format

Its main differentiator is “objective status monitoring”: it uses data generated through patients’ everyday smartphone usage to infer changes in their condition without requiring active input. For example, keyboard typing errors and typing speed can indirectly indicate hand pain or joint stiffness; the phone’s accelerometer can track gait, physical activity, and fatigue; and patterns in calls, text messages, and social media usage can help record worsening depression. The platform also provides PROMs, or patient-reported outcome measures, and allows clinical staff to customize patient questionnaires according to clinic workflows or drug trial requirements. The web app can be used to monitor symptoms, configure PROMs, and prepare electronic case report forms.

Pricing, Deployment, and Integrations

The collected information does not disclose plans, pricing, free trials, procurement processes, or payment methods, so its cost-effectiveness cannot be assessed at this stage. In terms of deployment, only the existence of a mobile app and a web app can be confirmed; it is not clear whether the service is cloud-only, privately deployable, or available in a hybrid model. Third-party integrations, APIs, developer documentation, access control, and team collaboration features are also not mentioned.

Pros and Cons

Its strength lies in its passive data collection approach, which is well suited to long-term follow-up and clinical research while reducing the burden on patients to actively submit reports. It also covers both PROMs and eCRF, giving it the potential to connect care delivery and trial scenarios. The main drawback is that public information remains largely conceptual and focused on the R&D stage, with limited details on commercial maturity, medical device certification status, data security, privacy compliance, and system integration capabilities—all key factors for procurement decisions.

Who It’s For and Access from China

It is best suited for healthcare institutions and research teams evaluating remote monitoring, clinical research, or drug trial use cases for rheumatic diseases. Its accessibility from China is unknown. For domestic use in China, organizations would need to carefully verify network availability, cross-border data transfer requirements, medical device compliance, payment and procurement methods, as well as local alternatives in ePRO/eCOA, remote patient monitoring, or clinical trial data capture platforms.